Regional Differences in the Clinical Presentation of Registry-Recorded Renal Cell Carcinoma and Area-Level Healthcare Resource Indicators: A Multicenter Study in Miyazaki, Japan

Background/Objectives: Healthcare resources are unevenly distributed across Miyazaki Prefecture, Japan. We examined regional differences in the clinical presentation of renal cell carcinoma (RCC) recorded in the Miyazaki Urological Cancer Database (MUCD), together with area-level healthcare resource indicators. Methods: We performed a retrospective descriptive observational analysis of prospectively collected data from the multicenter MUCD registry. After deduplication and rechecking eligibility, 540 patients with a documented diagnosis date within the study period (1 April 2019–31 March 2024) were included (Central/Southern, n = 333; Western, n = 116; Northern, n = 91). The three main clinical outcomes were adjusted for age and sex, with clustering by registering facility taken into account. Results: Presentation with predefined local symptoms occurred in 18.6%, 19.0%, and 34.1% of patients in the Central/Southern, Western, and Northern areas, respectively. Compared with Central/Southern, the adjusted odds ratio for predefined local symptoms in the Northern area was 2.30 (95% CI, 1.39–3.81). Median tumor size was 3.8, 4.4, and 5.0 cm, respectively; the adjusted mean difference for Northern versus Central/Southern was 1.24 cm (95% CI, 0.65–1.82). Clinical M1 disease was recorded in 10.2%, 12.1%, and 19.8%, respectively; the global test accounting for facility clustering yielded p = 0.076, and the Holm-adjusted p value for Northern versus Central/Southern was 0.082. Urologist density in 2024 was 8.7, 8.0, and 5.3 per 100,000 population, respectively. Conclusions: Regional differences were observed in the clinical presentation of MUCD-recorded RCC and in area-level healthcare resource availability. These findings are descriptive and hypothesis-generating and do not show that differences in resource availability caused the observed clinical patterns.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-09-10
DOI
https://doi.org/10.3390/healthcare14182940
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Regional Differences in the Clinical Presentation of Registry-Recorded Renal Cell Carcinoma and Area-Level Healthcare Resource Indicators: A Multicenter Study in Miyazaki, Japan

Kentaro Kuroiwa, Chie Onizuka, Toyoharu Kamibeppu, Michikazu Nakai et al.
Healthcare
Multiple and Secondary Primary Cancers
article

Regional Differences in the Clinical Presentation of Registry-Recorded Renal Cell Carcinoma and Area-Level Healthcare Resource Indicators: A Multicenter Study in Miyazaki, Japan

Kentaro Kuroiwa, Chie Onizuka, Toyoharu Kamibeppu, Michikazu Nakai, Hironobu Wakeda, Shoichi Kimura, Atsuro Sawada, Takeshi Yamasaki, Masafumi Nagano, Katsuhisa Mori, Hiromasa Tsukino, Toshiyuki Kamoto, Toshio Kamimura, Yasuhiro Yamashita, Soichiro Fukuda, Toyoharu Nagata, Naoki Terada, Takahiro Shitamura, Toshiyuki Takehara
article en

Abstract

Background/Objectives: Healthcare resources are unevenly distributed across Miyazaki Prefecture, Japan. We examined regional differences in the clinical presentation of renal cell carcinoma (RCC) recorded in the Miyazaki Urological Cancer Database (MUCD), together with area-level healthcare resource indicators. Methods: We performed a retrospective descriptive observational analysis of prospectively collected data from the multicenter MUCD registry. After deduplication and rechecking eligibility, 540 patients with a documented diagnosis date within the study period (1 April 2019–31 March 2024) were included (Central/Southern, n = 333; Western, n = 116; Northern, n = 91). The three main clinical outcomes were adjusted for age and sex, with clustering by registering facility taken into account. Results: Presentation with predefined local symptoms occurred in 18.6%, 19.0%, and 34.1% of patients in the Central/Southern, Western, and Northern areas, respectively. Compared with Central/Southern, the adjusted odds ratio for predefined local symptoms in the Northern area was 2.30 (95% CI, 1.39–3.81). Median tumor size was 3.8, 4.4, and 5.0 cm, respectively; the adjusted mean difference for Northern versus Central/Southern was 1.24 cm (95% CI, 0.65–1.82). Clinical M1 disease was recorded in 10.2%, 12.1%, and 19.8%, respectively; the global test accounting for facility clustering yielded p = 0.076, and the Holm-adjusted p value for Northern versus Central/Southern was 0.082. Urologist density in 2024 was 8.7, 8.0, and 5.3 per 100,000 population, respectively. Conclusions: Regional differences were observed in the clinical presentation of MUCD-recorded RCC and in area-level healthcare resource availability. These findings are descriptive and hypothesis-generating and do not show that differences in resource availability caused the observed clinical patterns.

HealthcareVol. 14(18)
University of Fukui (JP), University of Miyazaki (JP), Obayashi (Japan) (JP), Taoka Hospital (JP), Miyazaki Prefectural Hospital (JP), Koga Hospital (JP), University of Miyazaki Hospital (JP), Surugadai Nihon University Hospital (JP), Fujieda Municipal General Hospital (JP), National Institute of Technology, Miyakonojo College (JP), Saiseikai Shigaken Hospital (JP), Toshima Hospital (JP)
Decent work and economic growth
Openalex Percentile: Top 10%
Multiple and Secondary Primary Cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.